Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, is pleased to announce that…

First BPH patient treated using Profound’s TULSA-PRO with TULSA-AI Volume Reduction - BioTuesdays

Profound Medical (NASDAQ: PROF; TSX: PRN) announced that the first commercial benign prostatic hyperplasia (BPH) treatment utilizing the TULSA-PRO system’s new TULSA-AI Volume Reduction Module was successfully conducted yesterday by Naveen Kella, MD, founder of The Urology Place, and an adjunct assistant professor for the UT Health Science Center San Antonio. The TULSA procedure, performed using the TULSA-PRO system, has the potential to become …

BioProst Review: Can It Help with BPH Symptoms Effectively?

Prostate health issues can arise due to various factors, including age, genetics, and lifestyle choices. As men age, the prostate gland may naturally enlarge, leading to conditions such as benign prostatic hyperplasia (BPH). This enlargement can cause discomfort and inconvenience, notably through urinary symptoms such as frequent urges to urinate, nocturia (waking up at night to urinate), and a weak urine stream. Lifestyle factors, such as diet …